🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SHR4640 tablets is a highly selective and potent URAT1 inhibitors,study num...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-15
Trial ID
NCT05513976
Treatments Being Tested
The goal of this clinical trial is to compare the changes in serum urate le...
Status
Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2025-09-10
Trial ID
NCT06622603
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of HR09150...
Status
Unknown
Location
Multiple Locations
Start Date
2022-04-30
Trial ID
NCT05347498
The purpose of this study was to explore the effects of uric acid control o...
Status
Unknown
Location
Shanghai Xuhui Central Hospital
Start Date
2020-04-10
Trial ID
NCT04398251
Treatments Being Tested
This study is a randomized, double-blind, non-befloxacin-controlled, multic...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07498647
Treatments Being Tested
IBI128 (Tigulixostat) is a novel non-purine selective inhibitor of xanthine...
Status
Completed
Location
Shanghai Fudan University HuaShan Hospital
Start Date
2024-07-10
Trial ID
NCT06501534
Treatments Being Tested
This study was designed to compare and evaluate the pharmacokinetic charact...
Status
Completed
Location
Korea University Anam Hospital
Start Date
2012-01
Trial ID
NCT01563432
The aim of this study is to evaluate the efficacy and safety of simiaowan i...
Status
Unknown
Location
Guang'anmen Hospital
Start Date
2019-09-01
Trial ID
NCT04069325
Treatments Being Tested
Febuxostat is a potent, nonpurine, selective inhibitor of Xanthine oxidase ...
Status
Completed
Location
Dow University of Health Sciences
Start Date
2013-11
Trial ID
NCT02600780
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of HR0915...
Status
Unknown
Location
Multiple Locations
Start Date
2024-06
Trial ID
NCT06414837